Please provide your email address to receive an email when new articles are posted on . “ANCA-associated vasculitis is associated with increased early mortality and a high risk of end-stage renal ...

A recent study suggests treatment with glucocorticoids after loss of ambulation can preserve late-stage functional abilities, respiratory function, and cardiac function in patients with Duchenne ...

A retrospective analysis found glucocorticoid treatment to reduce comorbidities in adults with Duchenne muscular dystrophy (DMD) and assessed the relationship between anthropometric measures and ...

Due to their immunosuppressive properties, systemic glucocorticoids are estimated to be used by 0.5% to 3% of the population annually. Glucocorticoids are effective, but their use comes with some ...

Please provide your email address to receive an email when new articles are posted on . Providers should educate patients when prescribing glucocorticoid therapy. Tapering off glucocorticoids should ...

Patients with Duchenne muscular dystrophy (DMD) are prescribed corticosteroid anti-inflammatory drugs as standard of care, but long-term use comes with significant adverse effects. For individuals ...